vs

Side-by-side financial comparison of ACME UNITED CORP (ACU) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

ACME UNITED CORP is the larger business by last-quarter revenue ($52.3M vs $41.8M, roughly 1.3× Neuronetics, Inc.). ACME UNITED CORP runs the higher net margin — 1.9% vs -17.2%, a 19.1% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 13.8%). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -2.9%).

Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

ACU vs STIM — Head-to-Head

Bigger by revenue
ACU
ACU
1.3× larger
ACU
$52.3M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+71.9% gap
STIM
85.7%
13.8%
ACU
Higher net margin
ACU
ACU
19.1% more per $
ACU
1.9%
-17.2%
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-2.9%
ACU

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACU
ACU
STIM
STIM
Revenue
$52.3M
$41.8M
Net Profit
$985.0K
$-7.2M
Gross Margin
39.7%
52.0%
Operating Margin
3.3%
-12.1%
Net Margin
1.9%
-17.2%
Revenue YoY
13.8%
85.7%
Net Profit YoY
-40.4%
43.2%
EPS (diluted)
$0.24
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACU
ACU
STIM
STIM
Q1 26
$52.3M
Q4 25
$47.5M
$41.8M
Q3 25
$49.1M
$37.3M
Q2 25
$54.0M
$38.1M
Q1 25
$46.0M
$32.0M
Q4 24
$45.9M
$22.5M
Q3 24
$48.2M
$18.5M
Q2 24
$55.4M
$16.4M
Net Profit
ACU
ACU
STIM
STIM
Q1 26
$985.0K
Q4 25
$1.9M
$-7.2M
Q3 25
$1.9M
$-9.0M
Q2 25
$4.8M
$-10.1M
Q1 25
$1.7M
$-12.7M
Q4 24
$1.7M
$-12.7M
Q3 24
$2.2M
$-13.3M
Q2 24
$4.5M
$-9.8M
Gross Margin
ACU
ACU
STIM
STIM
Q1 26
39.7%
Q4 25
38.2%
52.0%
Q3 25
39.1%
45.9%
Q2 25
41.0%
46.6%
Q1 25
39.0%
49.2%
Q4 24
38.7%
66.2%
Q3 24
38.5%
75.6%
Q2 24
40.8%
74.0%
Operating Margin
ACU
ACU
STIM
STIM
Q1 26
3.3%
Q4 25
6.1%
-12.1%
Q3 25
6.1%
-19.6%
Q2 25
11.8%
-21.1%
Q1 25
5.3%
-34.4%
Q4 24
5.0%
-51.0%
Q3 24
6.1%
-41.7%
Q2 24
11.5%
-51.7%
Net Margin
ACU
ACU
STIM
STIM
Q1 26
1.9%
Q4 25
3.9%
-17.2%
Q3 25
3.9%
-24.3%
Q2 25
8.8%
-26.6%
Q1 25
3.6%
-39.6%
Q4 24
3.7%
-56.4%
Q3 24
4.6%
-72.0%
Q2 24
8.0%
-59.8%
EPS (diluted)
ACU
ACU
STIM
STIM
Q1 26
$0.24
Q4 25
$0.46
$-0.10
Q3 25
$0.46
$-0.13
Q2 25
$1.16
$-0.15
Q1 25
$0.41
$-0.21
Q4 24
$0.43
$-0.34
Q3 24
$0.54
$-0.44
Q2 24
$1.09
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACU
ACU
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$4.2M
$28.1M
Total DebtLower is stronger
$33.0M
$65.8M
Stockholders' EquityBook value
$116.7M
$22.4M
Total Assets
$195.2M
$141.6M
Debt / EquityLower = less leverage
0.28×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACU
ACU
STIM
STIM
Q1 26
$4.2M
Q4 25
$3.6M
$28.1M
Q3 25
$5.1M
$28.0M
Q2 25
$3.6M
$11.0M
Q1 25
$3.4M
$20.2M
Q4 24
$6.4M
$18.5M
Q3 24
$5.7M
$20.9M
Q2 24
$3.8M
$42.6M
Total Debt
ACU
ACU
STIM
STIM
Q1 26
$33.0M
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Stockholders' Equity
ACU
ACU
STIM
STIM
Q1 26
$116.7M
Q4 25
$117.6M
$22.4M
Q3 25
$115.8M
$27.4M
Q2 25
$113.7M
$27.1M
Q1 25
$108.3M
$35.5M
Q4 24
$107.0M
$27.7M
Q3 24
$106.3M
$9.4M
Q2 24
$104.0M
$19.4M
Total Assets
ACU
ACU
STIM
STIM
Q1 26
$195.2M
Q4 25
$171.0M
$141.6M
Q3 25
$173.0M
$145.5M
Q2 25
$170.9M
$134.7M
Q1 25
$163.0M
$142.0M
Q4 24
$162.2M
$140.9M
Q3 24
$165.5M
Q2 24
$173.5M
$96.8M
Debt / Equity
ACU
ACU
STIM
STIM
Q1 26
0.28×
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACU
ACU
STIM
STIM
Operating Cash FlowLast quarter
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACU
ACU
STIM
STIM
Q1 26
Q4 25
$8.2M
$908.0K
Q3 25
$7.1M
$-785.0K
Q2 25
$6.3M
$-3.5M
Q1 25
$-3.3M
$-17.0M
Q4 24
$6.4M
$-8.6M
Q3 24
$8.9M
$-5.4M
Q2 24
$6.9M
$-5.0M
Free Cash Flow
ACU
ACU
STIM
STIM
Q1 26
Q4 25
$7.3M
$692.0K
Q3 25
$301.0K
$-899.0K
Q2 25
$4.7M
$-3.8M
Q1 25
$-4.7M
$-17.2M
Q4 24
$4.7M
$-8.7M
Q3 24
$7.5M
$-5.8M
Q2 24
$4.4M
$-5.6M
FCF Margin
ACU
ACU
STIM
STIM
Q1 26
Q4 25
15.3%
1.7%
Q3 25
0.6%
-2.4%
Q2 25
8.7%
-9.9%
Q1 25
-10.2%
-53.8%
Q4 24
10.2%
-38.6%
Q3 24
15.6%
-31.3%
Q2 24
8.0%
-34.0%
Capex Intensity
ACU
ACU
STIM
STIM
Q1 26
Q4 25
1.9%
0.5%
Q3 25
13.8%
0.3%
Q2 25
3.0%
0.7%
Q1 25
2.9%
0.7%
Q4 24
3.7%
0.4%
Q3 24
2.8%
2.1%
Q2 24
4.5%
3.7%
Cash Conversion
ACU
ACU
STIM
STIM
Q1 26
Q4 25
4.34×
Q3 25
3.72×
Q2 25
1.33×
Q1 25
-2.02×
Q4 24
3.73×
Q3 24
3.99×
Q2 24
1.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons